|
AGLE
|
Aeglea BioTherapeutics, Inc.
|
US
|
NASDAQ
|
|
ALLR
|
Allarity Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BDTX
|
Black Diamond Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CDXS
|
Codexis, Inc.
|
US
|
NASDAQ
|
|
COGT
|
Cogent Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
US
|
NASDAQ
|
|
DAWN
|
Day One Biopharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
US
|
NASDAQ
|
|
ELAN
|
Elanco Animal Health Incorporated
|
US
|
NYSE
|
|
ELAT
|
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
|
US
|
NYSE
|
|
ERAS
|
Erasca, Inc
|
US
|
NASDAQ
|
|
ERYP
|
Erytech Pharma S.A.
|
US
|
NASDAQ
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IMRA
|
IMARA Inc.
|
US
|
NASDAQ
|
|
KALV
|
KalVista Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
KRON
|
Kronos Bio, Inc.
|
US
|
NASDAQ
|
|
NATR
|
Nature's Sunshine Products, Inc.
|
US
|
NASDAQ
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
US
|
NASDAQ
|